 "European Union agrees to pay 15.5 euros per dose for Pfizer shot: Report")
The European Union has agreed to pay 15.5 euros ($18.90) per dose for the Covid-19 vaccine developed by Pfizer and BioNTech, an internal EU document reviewed by Reuters showed.
The price, which is confidential and was negotiated for a total of 300 million doses, is slightly lower than the $19.50 per shot the United States agreed to pay for a first shipment of 100 million doses of the same vaccine, in line with what Reuters reported in November.
The EU document dated November 18 was circulated internally after the EU announced its supply deal with Pfizer and its German partner BioNTech on November 11.
The price, which is confidential and was negotiated for a total of 300 million doses, is slightly lower than the $19.50 per shot the United States agreed to pay for a first shipment of 100 million doses of the same vaccine, in line with what Reuters reported in November.
The EU document dated November 18 was circulated internally after the EU announced its supply deal with Pfizer and its German partner BioNTech on November 11.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%